24-Hour Intraocular Pressure (IOP) Control With Travoprost/Timolol Fixed Combination

Phase 3

Completed

• Conditions: Primary Open Angle Glaucoma; Exfoliation Syndrome

• Registration Number: NCT00331240
• Lead Sponsor: Aristotle University Of Thessaloniki

Brief Summary

The purpose of this study is to compare the short-term (8 week) mean 24-hour intraocular pressure control and safety of TravTim fixed combination given once in the evening with placebo once in the morning versus TravTim given once in the morning with placebo once in the evening in patients with open-angle glaucoma.

Detailed Description

Not available

Study Timeline

• Study Start: 2006-03
• Study First Submitted: 2006-05-26
• Study First Submitted QC: 2006-05-26
• Study First Posted: 2006-05-29
• Primary Completion: 2007-01
• Study Completion: 2007-02
• Status Verified: 2014-05
• Last Update Submitted: 2014-05-09
• Last Update Posted: 2014-05-12

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 32

Inclusion Criteria

• POAG
• Exfoliation syndrome

Read More

Exclusion Criteria

• Advanced glaucoma

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER

Trial Locations

Locations (1)

Glaucoma Unit, A University Dept of Ophthalmology, AHEPA Hospital; 🇬🇷 Thessaloniki, Greece